These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33857734)

  • 1. Covid-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease.
    Zifko U; Schmiedlechner T; Saelens J; Zifko K; Wagner M; Assadian O; Grisold W; Stingl H
    J Neurol Sci; 2021 Jun; 425():117438. PubMed ID: 33857734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of neurological patients with coronavirus 2019: an observational study of one centre.
    Zielińska-Turek J; Jasińska A; Kołakowska J; Szadurska J; Kosior DA; Dorobek M
    Neurol Neurochir Pol; 2021; 55(2):195-201. PubMed ID: 33528832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
    Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
    J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taste and Smell Disorders in COVID-19 Patients at a Local Healthcare Trust in Northern Italy: a Cross-Sectional Study.
    Piu N; Isabella A; Airoldi C; Aleni C; Sarro A; Faggiano F
    Ann Ig; 2022; 34(2):122-127. PubMed ID: 35088821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.
    Wohl DA; Barzin AH; Napravnik S; Davy-Mendez T; Smedberg JR; Thompson CM; Ruegsegger L; Gilleskie M; Weber DJ; Whinna HC; Miller MB
    PLoS One; 2021; 16(12):e0260879. PubMed ID: 34890441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological features and outcome in COVID-19: dementia can predict severe disease.
    Ghaffari M; Ansari H; Beladimoghadam N; Aghamiri SH; Haghighi M; Nabavi M; Mansouri B; Mehrpour M; Assarzadegan F; Hesami O; Sedaghat M; Farahbakhsh M; Lima BS
    J Neurovirol; 2021 Feb; 27(1):86-93. PubMed ID: 33417193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Dittrich S; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013665. PubMed ID: 32633856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smell and Taste Dysfunction in COVID-19 Is Associated With Younger Age in Ambulatory Settings: A Multicenter Cross-Sectional Study.
    Izquierdo-Domínguez A; Rojas-Lechuga MJ; Chiesa-Estomba C; Calvo-Henríquez C; Ninchritz-Becerra E; Soriano-Reixach M; Poletti-Serafini D; Villarreal IM; Maza-Solano JM; Moreno-Luna R; Villarroel PP; Mateos-Serrano B; Agudelo D; Valcarcel F; Del Cuvillo A; Santamaría A; Mariño-Sánchez F; Aguilar J; Vergés P; Inciarte A; Soriano A; Mullol J; Alobid I
    J Investig Allergol Clin Immunol; 2020; 30(5):346-357. PubMed ID: 32554337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis.
    Prakash A; Singh H; Sarma P; Bhattacharyya A; Dhibar DP; Balaini N; Shree R; Goyal M; Modi M; Medhi B
    Sci Rep; 2021 Jun; 11(1):12888. PubMed ID: 34145351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System.
    Morgado AM; Bezerra ALMS; Felix EBG; Júnior JCS; Pinto NB; Neto MLR; de Aguiar Rocha Martin AL
    Adv Exp Med Biol; 2021; 1353():197-215. PubMed ID: 35137375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of and symptom findings from an online symptom check-in tool for COVID-19 outpatient follow-up among a predominantly healthcare worker population.
    Kerr C; O' Regan S; Creagh D; Hughes G; Geary U; Colgan MP; Canning C; Martin Z; Merry C; Noonan N; Bergin C
    BMJ Open; 2021 Sep; 11(9):e050444. PubMed ID: 34588254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mood, Anxiety and Olfactory Dysfunction in COVID-19: Evidence of Central Nervous System Involvement?
    Speth MM; Singer-Cornelius T; Oberle M; Gengler I; Brockmeier SJ; Sedaghat AR
    Laryngoscope; 2020 Nov; 130(11):2520-2525. PubMed ID: 32617983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of neurological symptoms and complications of COVID-19.
    Chen X; Laurent S; Onur OA; Kleineberg NN; Fink GR; Schweitzer F; Warnke C
    J Neurol; 2021 Feb; 268(2):392-402. PubMed ID: 32691236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological consequences of COVID-19.
    Brola W; Wilski M
    Pharmacol Rep; 2022 Dec; 74(6):1208-1222. PubMed ID: 36180640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study.
    Amanat M; Rezaei N; Roozbeh M; Shojaei M; Tafakhori A; Zoghi A; Darazam IA; Salehi M; Karimialavijeh E; Lima BS; Garakani A; Vaccaro A; Ramezani M
    BMC Neurol; 2021 Mar; 21(1):116. PubMed ID: 33726699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.